|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:activities
|
reuptake inhibitor
|
|
gptkbp:approves
|
gptkb:United_States
|
|
gptkbp:brand
|
gptkb:Zyban
gptkb:Wellbutrin
gptkb:Bupropion
|
|
gptkbp:class
|
aminoketone antidepressant
|
|
gptkbp:clinical_trial
|
Phase III
|
|
gptkbp:contraindication
|
eating disorders
seizure disorder
|
|
gptkbp:dosage_form
|
gptkb:tablet
|
|
gptkbp:duration
|
7 to 12 weeks
|
|
gptkbp:effective_date
|
1997-12-30
|
|
gptkbp:formulation
|
extended-release tablet
|
|
gptkbp:has_ability
|
100 mg
150 mg
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Zyban
|
|
gptkbp:ingredients
|
gptkb:bupropion
|
|
gptkbp:interacts_with
|
gptkb:beer
antipsychotics
monoamine oxidase inhibitors
other antidepressants
|
|
gptkbp:is_atype_of
|
N06 A X12
|
|
gptkbp:is_available_in
|
tablet form
generic form
|
|
gptkbp:is_used_for
|
smoking cessation
|
|
gptkbp:legal_issue
|
prescription only
|
|
gptkbp:manager
|
oral
|
|
gptkbp:manufacturer
|
gptkb:Glaxo_Smith_Kline
|
|
gptkbp:marketed_as
|
gptkb:Zyban
|
|
gptkbp:packaging
|
blister pack
|
|
gptkbp:related_to
|
gptkb:Wellbutrin
|
|
gptkbp:requires
|
available online
|
|
gptkbp:scholarships
|
avoid alcohol
take with food
monitor for mood changes
|
|
gptkbp:side_effect
|
anxiety
dizziness
nausea
insomnia
dry mouth
|
|
gptkbp:treatment
|
improves mood
reduces cravings
increases quit rates
reduces withdrawal symptoms
|
|
gptkbp:bfsParent
|
gptkb:Glaxo_Smith_Kline
|
|
gptkbp:bfsLayer
|
3
|